Primer: Exelixis Inc (EXEL US) - Aug 2026
Exelixis' financial performance is robust, driven by the strong and growing sales of its flagship cabozantinib franchise (CABOMETYX®), which...
91 Views
𝛼SK or SearchENTITY
Exelixis Inc (EXEL US)
Exelixis Inc (EXEL US)
30
Analysis
Health Care • United States
Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.
morex